(Q57255480)

https://api.crossref.org/works/10.1111%2FNEUP.12149

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Ceruloplasmin metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Estimation of the gene frequency of aceruloplasminemia in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

NIDDM with a ceruloplasmin gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Aceruloplasminemia, an iron metabolic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Estimation of brain iron concentration in vivo using a linear relationship between regional iron and apparent transverse relaxation rate of the tissue water at 4.7T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Hepatic iron overload in aceruloplasminaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

The neurological presentation of ceruloplasmin gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Redox active iron accumulation in aceruloplasminemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Iron trafficking inside the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Use of desferrioxamine in the treatment of aceruloplasminemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149

Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNEUP.12149